» Articles » PMID: 28196483

Aortic Stiffening Precedes Onset of Heart Failure with Preserved Ejection Fraction in Patients with Asymptomatic Diastolic Dysfunction

Overview
Publisher Biomed Central
Date 2017 Feb 16
PMID 28196483
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Identifying which patients with diastolic dysfunction will progress to heart failure with preserved ejection fraction (HFpEF) remains challenging. The goal of this study is to determine whether increased vascular stiffness as identified on 2D transthoracic echocardiography (TTE) serves as a biomarker for the development of HFpEF in patients with diastolic dysfunction.

Methods: The study design is a matched retrospective case-control study. Subjects with diastolic dysfunction were divided into two groups based on whether they had a clinical diagnosis of HFpEF. The two groups were matched based on age, gender, race and body surface area, resulting in 77 matched pairs (n = 154). Data from the first TTE that documented diastolic dysfunction prior to the development of HFpEF was extracted along with baseline demographic and clinical data. Indices of vascular stiffness were measured and compared. A sub-group analysis was performed to compare diabetic subjects in Group 1 (n = 43) to those in Group 2 (n = 21).

Results: Group 1 had significantly decreased aortic distensibility as measured on the initial TTE when compared to Group 2 (1.9 ± 1.0 vs. 2.8 ± 1.8 cmdyne10, p = 0.01). In the diabetic subset, Group 1 had significantly less aortic strain (6.9 ± 3.3 vs. 9.7 ± 5.6%, p = 0.02) and aortic distensibility (1.8 ± 1.0 vs. 3.5 ± 2.6 cmdyne10, p = 0.02) compared to Group 2. Other indices of vascular stiffness did not differ significantly between groups.

Conclusions: This study demonstrates that increased proximal aortic stiffness is associated with the development of HFpEF in patients with asymptomatic diastolic dysfunction. Larger prospective studies are needed to further investigate this relationship.

Citing Articles

Association of Cardiac MRI-derived Aortic Stiffness with Early Stages and Progression of Heart Failure with Preserved Ejection Fraction.

Schulz A, Schellinger I, Backhaus S, Adler A, Lange T, Evertz R Radiol Cardiothorac Imaging. 2024; 6(4):e230344.

PMID: 39145733 PMC: 11369653. DOI: 10.1148/ryct.230344.


Inversion of Left Ventricular Axial Shortening: In Silico Proof of Concept for Treatment of HFpEF.

Goetz W, Yao J, Brener M, Puri R, Swaans M, Schopka S Bioengineering (Basel). 2024; 11(7).

PMID: 39061758 PMC: 11274197. DOI: 10.3390/bioengineering11070676.


The Stiffness of the Ascending Aorta Has a Direct Impact on Left Ventricular Function: An In Silico Model.

Goetz W, Yao J, Brener M, Puri R, Swaans M, Schopka S Bioengineering (Basel). 2024; 11(6).

PMID: 38927839 PMC: 11200724. DOI: 10.3390/bioengineering11060603.


Clinical Evidence and Proposed Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect?.

Deschaine B, Verma S, Rayatzadeh H Card Fail Rev. 2022; 8:e23.

PMID: 35846984 PMC: 9272408. DOI: 10.15420/cfr.2022.11.


Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction.

Chi C, Liu Y, Xu Y, Xu D Front Cardiovasc Med. 2021; 8:707162.

PMID: 34458336 PMC: 8385653. DOI: 10.3389/fcvm.2021.707162.


References
1.
Chow B, Rabkin S . The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis. Heart Fail Rev. 2015; 20(3):291-303. DOI: 10.1007/s10741-015-9471-1. View

2.
Massie B . Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure: good news and bad. J Am Coll Cardiol. 2003; 41(11):2018-21. DOI: 10.1016/s0735-1097(03)00395-4. View

3.
Kawaguchi M, Hay I, Fetics B, Kass D . Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation. 2003; 107(5):714-20. DOI: 10.1161/01.cir.0000048123.22359.a0. View

4.
Wang Y, Wang Q, Wang L, Wu Y, Wang Z, Cameron J . Body surface area as a key determinant of aortic root and arch dimensions in a population-based study. Exp Ther Med. 2013; 5(2):406-410. PMC: 3570135. DOI: 10.3892/etm.2012.839. View

5.
Fang Z, Prins J, Marwick T . Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004; 25(4):543-67. DOI: 10.1210/er.2003-0012. View